Overexpression of Skp2 partially rescued the growth inhibition induced by triol (Fig. 9), indicating that other pathways or mechanisms, such as LXR signaling (Fig. 11) or cytoskeletal signaling (Fig. 12), were probably involved in the growth inhibition caused by triol in prostate cancer cells. Here, SKP2 is linked to prostate cancer.